May 27, 2020: "Novartis announced that new ofatumumab data from the Phase III ASCLEPIOS trials and the Phase II APLIOS trial were presented virtually...
May 27, 2020: "Novartis announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, to be presented during the ASCO20...
May 26, 2020: "Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a closely held biotechnology company, announced that...
May 26, 2020: "Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicated to addressing urgent,...
May 27, 2020: "Roche announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living...
“A clinical study report (CSR) on a clinical trial is a document, typically very long, providing much detail about the methods and results of a trial.
A...
May 25, 2020: "Sanofi announced its intent to sell its equity investment in Regeneron through a registered public offering and related share repurchase by...
May 26, 2020: "Novartis announces data from its Migraine Care pilot program which was created in collaboration with patient groups and leading experts in...
May 21, 2020: "The U.S. FDA announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
The FDA posted a list of antibody tests that...
"The use of hydroxychloroquine or chloroquine in COVID-19 is based on popular publicity of limited, uncontrolled trials, indicating that the combination of hydroxychloroquine with...
21 May 2020: "GlaxoSmithKline and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s innovative...